This inventor holds 5 USPTO granted patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The Penn State Research Foundation, The United States of America as Represented by the Department of Health. Active years: 1994-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gaithersburg, MD (US) (1994)
- Hummelstown, PA (US) (1997 - 2003)
Company Filing History:
2 out of 3,693 
1 out of 1,339 
1 out of 1,217 
Years Active: 1994-2003
Title: Waldemar Debinski: Innovator in Tumor Targeting Technologies
Introduction
Waldemar Debinski is a notable inventor based in Hummelstown, PA (US). He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 5 patents, Debinski has focused on developing methods and compositions for specifically targeting tumor cells.
Latest Patents
One of his latest patents is titled "IL-13 receptor specific chimeric proteins and uses thereof." This invention provides a method and compositions for delivering an effector molecule specifically to tumor cells bearing an IL-13 receptor. The method involves using a chimeric molecule that includes an effector molecule attached to a circularly permuted IL-13, which binds specifically to the IL-13 receptor. Additionally, he has developed compositions that include chimeric molecules with modified Pseudomonas exotoxin attached to cpIL-13. Another significant patent is focused on "Compositions and methods for specifically targeting tumors." This invention outlines a method for delivering an effector molecule to tumor cells using a chimeric molecule that binds to the IL-13 receptor in the presence of an IL-4R blocker.
Career Highlights
Throughout his career, Waldemar Debinski has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and The United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding and treatment of cancer.
Collaborations
Debinski has collaborated with notable colleagues such as Raj K Puri and Ira H Pastan, contributing to the development of innovative cancer therapies.
Conclusion
Waldemar Debinski's work in the field of tumor targeting technologies has led to significant advancements in cancer treatment. His innovative patents and collaborations highlight his commitment to improving patient outcomes through targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile